Search

There are very few investigations about sex differences in suicide which include some other variables (e.g. age, profession etc). Data which concern suicide sex differences are obscure and usually are given in statistical accounts of causes of death. The aim of our study was to investigate sex differences in realized suicides within the city of Belgrade during the last eight year period. Data was taken from the index records of suicide in the city of Belgrade held at the Institute for Informatics and Statistics. We took sex as the main observed variable, and analyzed nine other variables as related to sex. Statistical analysis was done by using the crude specific rate. The variability of the rate was estimated by computing a confidence interval. The results of our study gave the profile of males and females who committed suicide in Belgrade in the period of the last eight years. Although there were significant quantitative differences, the female/male profile of completed suicides is similar, and differs only in the method of suicide: both males and females choose hanging, drowning and suffocation as the most common method of suicide, while poisoning is on the second most common method chosen by females and firearms the second most common method for males. The frequency of suicide, in both sexes, showed a tendency to decrease over the observed period (the highest suicide rate was in 2000- females 9.7, males 19.7, and the lowest in 2004- females 4.5 males 9.1). Male to female suicide rate ratio was 2 to 1. Sex differences were registered in all of the observed nine variables.

Aim: This open-label, multicentre study investigated the clinical efficacy of liquid peroral risperidone in psychotic disorders, the patients' attitudes toward the study medication vs. previous antipsychotic medication and also psychiatrists' opinion of it., Method: Eighty one patients with psychotic disorder entered the study during 2004. At the baseline (T0), the treatment started with peroral risperidone liquid and lasted for 6 months (T2), with one visit a month after the baseline (T1). Clinical improvement was evaluated using PANSS and CGI, while extrapyramidal side effects were measured by the AIMS scale. The patients' attitudes were evaluated by 3-choice 3-item questionnaire designed for the purposes of present study. Moreover, psychiatrists were asked about their opinion regarding clinical improvement and compliance comparing liquid peroral versus risperidone-tablets., Results: PANSS and CGI scores yielded clinical improvement (p<0.001, DF=151 and p<0.001, DF=151, respectively). Eighty three per cent of patients preferred peroral liquid risperidone for continuation of treatment. The psychiatrists agreed with the patients in deciding to continue treatment with peroral liquid risperidone (83%) because of better tolerability in 88% patients, better cooperation in 82% and more precise dosage in 80% patients. In terms of mental state, it was observed that during the study symptomatology had worsened in 3% of the study patients, in 6% there were no changes, while all others improved (26% moderately, 65% highly). conclusions: Peroral risperidone liquid was effective and well tolerated in patients with psychotic disorders. The patients' as well as their doctors' attitudes expressed satisfaction with the use of the risperidone peroral formulation. This is the only SAG available in peroral liquid formulation.